Highest CV risk may warrant SGLT2 inhibitor rather than GLP-1 receptor agonist
The rate of heart failure hospitalization rises more than the rate of major adverse cardiovascular events as vascular risk increases in people with type 2 diabetes, report researchers.
CGM data highlight need for early glucose control in type 1 diabetes pregnancies
Continuous glucose monitoring metrics show early divergence between pregnant women with type 1 diabetes who subsequently give birth to normal weight versus large for gestational age infants, study findings indicate.
Type 1 diabetes increases MI case–fatality risk
Results from a nationwide registry study show that having type 1 diabetes places people at a significantly increased risk for dying within a year after having a myocardial infarction.
